Arlene S. Bridges

3.9k citations

53 papers · 3.1k indexed · h-index 31

Co-authors: Christina M. Van Itallie James M. Anderson Alan S. Fanning Kim L. R. Brouwer Angela D. M. Kashuba Naser L. Rezk Amanda Corbett Jennifer L. Holmes
Topics: Drug Transport and Resistance Mechanisms (19 papers)Pharmacogenetics and Drug Metabolism (11 papers)Trypanosoma species research and implications (10 papers)
Cited by: Neurology Virology Pharmacology
Journals: Nature Journal of Biological Chemistry PLoS ONE
Partner nations: United States Switzerland Netherlands

In The Last Decade

Arlene S. Bridges

52 papers receiving 3.1k citations

Peers

Countries citing papers authored by Arlene S. Bridges

Since Specialization

Citations

This map shows the geographic impact of Arlene S. Bridges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlene S. Bridges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlene S. Bridges more than expected).

Fields of papers citing papers by Arlene S. Bridges

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arlene S. Bridges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlene S. Bridges. The network helps show where Arlene S. Bridges may publish in the future.

Co-authorship network of co-authors of Arlene S. Bridges

This figure shows the co-authorship network connecting the top 25 collaborators of Arlene S. Bridges. A scholar is included among the top collaborators of Arlene S. Bridges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arlene S. Bridges. Arlene S. Bridges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice 2013 ·Clinical Cancer Research ·Jerry Usary,Wei Zhao,David B. Darr,Patrick J. Roberts,Mei Liu,(unknown),Olga Karginova,(unknown),Austin J. Combest,Arlene S. Bridges,Aleix Prat,Maggie C.U. Cheang,Jason I. Herschkowitz,Jeffrey M. Rosen,William C. Zamboni,Norman E. Sharpless,Charles M. Perou	40
2	Intestinal First-Pass Metabolism by Cytochrome P450 and Not P-Glycoprotein Is the Major Barrier to Amprenavir Absorption 2013 ·Drug Metabolism and Disposition ·(unknown),Arlene S. Bridges,Dhiren R. Thakker	7
3	P-Glycoprotein Increases Portal Bioavailability of Loperamide in Mouse by Reducing First-Pass Intestinal Metabolism 2013 ·Drug Metabolism and Disposition ·(unknown),(unknown),Arlene S. Bridges,Dhiren R. Thakker	19
4	Valproic acid reduces the tolerability of temsirolimus in children and adolescents with solid tumors 2013 ·Anti-Cancer Drugs ·Donald W. Coulter,Christine M. Walko,Jai N. Patel,Billie M. Moats‐Staats,(unknown),(unknown),Wasiuddin A. Khan,Arlene S. Bridges,Allison M. Deal,Javier Oesterheld,Ian J. Davis,Julie Blatt	14
5	Safety, Pharmacokinetic, and Efficacy Studies of Oral DB868 in a First Stage Vervet Monkey Model of Human African Trypanosomiasis 2013 ·PLoS neglected tropical diseases ·John K. Thuita,Kristina Wolf,Grace Murilla,Qiang Liu,(unknown),Yao Chen,Arlene S. Bridges,(unknown),Mohamed A. Ismail,Shelley Ching,David W. Boykin,James Edwin Hall,Richard R. Tidwell,Mary F. Paine,Reto Brun,Michael Zhuo Wang	17
6	Hepatic Basolateral Efflux Contributes Significantly to Rosuvastatin Disposition II: Characterization of Hepatic Elimination by Basolateral, Biliary, and Metabolic Clearance Pathways in Rat Isolated Perfused Liver 2013 ·Journal of Pharmacology and Experimental Therapeutics ·Nathan D. Pfeifer,Arlene S. Bridges,Brian C. Ferslew,Rhiannon N. Hardwick,Kim L. R. Brouwer	28
7	CYP1A1 and CYP1B1-Mediated Biotransformation of the Antitrypanosomal Methamidoxime Prodrug DB844 Forms Novel Metabolites Through Intramolecular Rearrangement 2013 ·Journal of Pharmaceutical Sciences ·(unknown),Sihyung Yang,John H. Ansede,Chad E. Stephens,Arlene S. Bridges,Robert D. Voyksner,Mohamed A. Ismail,David W. Boykin,Richard R. Tidwell,James Edwin Hall,Michael Zhuo Wang	9
8	Compartmental and Enzyme Kinetic Modeling To Elucidate the Biotransformation Pathway of a Centrally Acting Antitrypanosomal Prodrug 2012 ·Drug Metabolism and Disposition ·(unknown),Garrett R. Ainslie,Arlene S. Bridges,Mohamed A. Ismail,David W. Boykin,Richard R. Tidwell,Dhiren R. Thakker,Mary F. Paine	6
9	Impact of Organic Solvents on Cytochrome P450 Probe Reactions: Filling the Gap with (S)-Warfarin and Midazolam Hydroxylation 2012 ·Drug Metabolism and Disposition ·(unknown),Elizabeth A. Connolly,Arlene S. Bridges,Larry C. Wienkers,Mary F. Paine	19
10	A Mouse Diversity Panel Approach Reveals the Potential for Clinical Kidney Injury Due to DB289 Not Predicted by Classical Rodent Models 2012 ·Toxicological Sciences ·Alison H. Harrill,Kristina DeSmet,Kristina Wolf,Arlene S. Bridges,J. Scott Eaddy,C. Lisa Kurtz,J. E. Hall,Mary F. Paine,Richard R. Tidwell,Paul B. Watkins	44
11	Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons 2011 ·Nature ·Hsien‐Sung Huang,John A. Allen,Angela M. Mabb,Ian King,Jayalakshmi Miriyala,Bonnie Taylor‐Blake,Noah Sciaky,(unknown),Hyeong-Min Lee,Xin Chen,Jian Jin,Arlene S. Bridges,Mark J. Zylka,Bryan L. Roth,Benjamin D. Philpot	287
12	Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach 2011 ·Glycobiology ·Yongmei Xu,Zhen Wang,Renpeng Liu,Arlene S. Bridges,Xuefei Huang,Jian Liu	19
13	ZO-1 Stabilizes the Tight Junction Solute Barrier through Coupling to the Perijunctional Cytoskeleton 2009 ·Molecular Biology of the Cell ·Christina M. Van Itallie,Alan S. Fanning,Arlene S. Bridges,James M. Anderson	364
14	Sex-Dependent Disposition of Acetaminophen Sulfate and Glucuronide in the in Situ Perfused Mouse Liver 2009 ·Drug Metabolism and Disposition ·Jin Kyung Lee,Koji Abe,Arlene S. Bridges,Nita Patel,Thomas J. Raub,Gary M. Pollack,Kim L. R. Brouwer	20
15	Claudin‐2‐dependent Changes in Noncharged Solute Flux Are Mediated by the Extracellular Domains and Require Attachment to the PDZ‐scaffold 2009 ·Annals of the New York Academy of Sciences ·Christina M. Van Itallie,Jennifer L. Holmes,Arlene S. Bridges,James M. Anderson	30
16	Plasma Bile Acid Concentrations in Patients with Human Immunodeficiency Virus Infection Receiving Protease Inhibitor Therapy: Possible Implications for Hepatotoxicity 2009 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown),Naser L. Rezk,Arlene S. Bridges,Amanda Corbett,Hsiao‐Chuan Tien,Kim L. R. Brouwer,Angela D. M. Kashuba	16
17	The density of small tight junction pores varies among cell types and is increased by expression of claudin-2 2008 ·Journal of Cell Science ·Christina M. Van Itallie,Jennifer L. Holmes,Arlene S. Bridges,Jody L. Gookin,(unknown),William R. Proctor,Oscar R. Colegio,James M. Anderson	319
18	Using a 3-O-Sulfated Heparin Octasaccharide To Inhibit the Entry of Herpes Simplex Virus Type 1 2008 ·Biochemistry ·Ronald J. Copeland,Arun Balasubramaniam,Vaibhav Tiwari,Fuming Zhang,Arlene S. Bridges,Robert J. Linhardt,Deepak Shukla,Jian Liu	115
19	Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice 2007 ·Drug Metabolism and Disposition ·Xianbin Tian,Maciej J. Zamek‐Gliszczynski,Jun Li,Arlene S. Bridges,Ken-ichi Nezasa,Nita Patel,Thomas J. Raub,Kim L. R. Brouwer	37
20	Human Enteric Microsomal CYP4F Enzymes O-Demethylate the Antiparasitic Prodrug Pafuramidine 2007 ·Drug Metabolism and Disposition ·Michael Zhuo Wang,Judy Qiju Wu,Arlene S. Bridges,Darryl C. Zeldin,Sally Kornbluth,Richard R. Tidwell,James Edwin Hall,Mary F. Paine	45

About Arlene S. Bridges

Arlene S. Bridges is a scholar working on Pharmacology, Transplantation and Oncology, having authored 53 papers that have together received 3.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (19 papers), Pharmacogenetics and Drug Metabolism (11 papers) and Trypanosoma species research and implications (10 papers). The work is most often cited by research in Neurology (431 citations), Virology (233 citations) and Pharmacology (415 citations). Arlene S. Bridges has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Christina M. Van Itallie, James M. Anderson, Alan S. Fanning, Kim L. R. Brouwer, Angela D. M. Kashuba, Naser L. Rezk, Amanda Corbett, Jennifer L. Holmes, Oscar R. Colegio and Jody L. Gookin. Their work appears in journals such as Nature, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact